Compared with cells from control subjects, cytotoxic T lymphocytes (CTLs, CD3+CD8+ cells) from CML patients showed higher levels of PD-1, while CML cells expressed higher levels of PD-L1 (157). Here, CD8A is linked to chronic myelogenous leukemia, BCR-ABL1 positive.